Automated and Personalized Outreach to Level the Playing Field for Colorectal Cancer Screening
Menée aux Etats-Unis auprès de 1 046 745 personnes âgées de 50 à 75 ans et incluses dans un programme de dépistage du cancer colorectal par coloscopie, sigmoïdoscopie ou test FIT, cette étude évalue, en fonction de l'origine ethnique, de l'âge et du sexe, la performance de stratégies de sensibilisation automatisées (envois de courriers et de kits de test FIT, appels téléphoniques automatisés, courriers de rappel) suivies d'interventions personnalisées (appels téléphoniques, messages électroniques, offres de dépistages) pour améliorer le taux de participation au programme de dépistage
Approximately 150 000 people in the US will be diagnosed with colorectal cancer in 2024, and another 50 000 will die, marking another year where colorectal cancer remains the second leading cause of cancer death for men and women combined. Comprehensive screening can prevent colorectal cancer through treatment of precancerous polyps and can detect asymptomatic early-stage cancer while it is still curable. Yet nearly half of eligible Americans are not up to date with colorectal cancer screening, falling far short of the 80% target set by the National Colorectal Cancer Roundtable. Racial and ethnic minoritized individuals are the least likely to complete screening, the most likely to be diagnosed with advanced disease, and the most likely to die of colorectal cancer. Robust data indicate that the elimination of racial and ethnic disparities in stage at diagnosis (through screening) would reduce disparities in colorectal cancer survival by an estimated 35%. Increasing rates of colorectal cancer screening—especially among racial and ethnic minoritized groups—is an attractive goal.
JAMA Network Open , éditorial en libre accès, 2023